Clinical evaluation of spasticity;Évaluation clinique de la spasticité

Neurochirurgie

Volumn 49, Issue 2-3 II, 2003, Pages 190-198

  Smaïl, D Ben ^a   Kiefer, C ^a   Bussel, B ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Clinical evaluation; Contracture; Dystonia; Intra thecal baclofen; Spasticity

Indexed keywords

CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; EXPECTATION; HUMAN; MOTONEURON; MOTOR DYSFUNCTION; MUSCLE CONTRACTILITY; NEUROLOGIC EXAMINATION; PATIENT ATTITUDE; SPASTICITY; MOTOR NEURON DISEASE; PATHOLOGY; REVIEW; TREATMENT OUTCOME;

HUMANS; MOTOR NEURON DISEASE; MUSCLE SPASTICITY; NEUROLOGIC EXAMINATION; TREATMENT OUTCOME;

EID: 0037901812     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. ALBRIGHT AL, BARRON WB, FASICK MP, POLINKO P, JANOSKY J. Continuous intrathecal Baclofen infusion for spasticity of cerebral origin. JAMA 1993; 270: 2475-2477.
2. ASHWORTH B, et al. Preliminary trial of carisoprodal in multiple sclerosis. Practionner 1964; 192: 540-542.
3. AZOUVI P, et al. Effect of intrathecal baclofen on the monosynaptic reflex in humans: evidence for a postsynaptic action. J Neurol Neurosurg Psychiatr 1993; 56: 515-519.
4. AZOUVI P, MANE M, THIEBAUT JB, DENYS P, REMYNERIS O, BUSSEL B. Intrathecal baclofen Administration for Control of severe Spinal spasticity: functionnal improvement/long-term follow-up. Arch Phys Med Rehabil 1996; 77: 35-39.
5. BAJD T, BOWMAND B. Testing and modelling of spasticity. J Biomed Engeneer 1982; 4: 90-96.
6. BOHANNON RW, SMITH MB. Inter-rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
7. BRADSTATER ME, DE BRUIN H, GOWLAND C, CLARKE BM. Hemiplegic gait: analysis of temporal variables. Arch Phys Med Rehabil 1983; 64: 583-587.
8. BURBAUD P, WIART L, DUBOS JL. A randomised, double-blind trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatr 1996; 61: 256-259.
9. COLLIN C, WADE D, DAVIS S, HORNE B. The Barthel ADL index: a reliability study. International Disability Studies 1988; 10: 61-63.
10. DARIO A, SCAMONI C, BONO G, GHEZZI A, ZAFFARONI M Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion. Funct Neurol 2001; 16: 311-315.
11. DEMEURISSE G, DEMOL O, ROBAYE E. Motor evaluation in vascular hemiplegia. Eur Neurol 1980; 19: 382-389.
12. DENNY-BROWN D. The basal ganglia and their relation to disorders of movement. Oxford, London: Oxford University Press, 1962.
13. DIETZ V, QUINTERN J, BERGER W. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 1981; 104: 431-449.
14. GOFF B. Grading of spasticity and its effect on voluntary movement. Physiotherapy 1976; 62: 358-361.
15. GOLDSPINK G, Williams PE. Muscle fibre and connective tissue changes associated with use and disuse. In: Ada A, Canning C, eds. Foundations for practice. Topics in neurological physiotherapy. London: Heinemann, 1990: 197-218.
16. GRANGER CV, HAMILTON BB, SHERWIN FS. Guide for the use of the uniform data set for medical rehabilitation. Uniform Data System for Medical Rehabilitation Project Office, Buffalo General Hospital, New York, 1986.
17. HESSE S, LÜCKE D, MALEZIC M, BERTELT C, FRIEDRICH H, GREGORIC M, MAURITZ KH. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatr 1994; 57: 1321-1324.
18. HUNT SM, MCKENNA SP, MCEWANN J. A quantitative approach to percieved health status: a validation study. J Epidemiol Comm Health 1980; 34: 281-286.
19. HUSKINSSON EC. Measurement of pain. Lancet 1974; 9: 1127-1131.
20. HYMAN N, BARNES M, BHAKTA B, CZENS A, BAKHEIT M, KRECZY-KLEEDORFER B, et al. Botulinum toxin (Dysport*) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatr 2000; 68: 707-712.
21. JEBSEN RH, TRIESCHMANN R, TROTTER N, HOWARD LA. An objective and standardised test of hand function. Arch Phys Rehabil 1969; 50: 311-319.
22. JIMENEZ I, et al. Differential effects of (-) - Baclofen on Ia and descending monosynaptic EPSPs. Exp Brain res 1991; 85: 103-113.
23. LANCE JW, et al. Spasticity: disorder of motor control. Chicago: Year Book Medical, 1980: 485-494.
24. LIDDEL EGT, SHERRINGTON CS. Reflexes in response to stretch (myotatic reflexes). Proceedings of the Royal Society, London, series B 96: 212-242.
25. LINCOLN NB, LEADBETTER D. Assessment of motor function in stroke patients. Physiotherapy 1979; 65: 48-51.
26. MATHIOWETZ V, WEBER K, KASHMAN N. Adult norms for the nine-hole peg test of finger dexterity. Occup Ther J Res 1985; 5: 24-37.
27. MATHIOWETZ V, WEBER K, VOLLAND G, KASHMAN N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am 1984; 92: 222-226.
28. MATHIOWETZ V, VOLLAND G, KASHMAN N, Weber K. Adult norms for the Box and Block test of manual dexterity. Am J Occup Ther 1985; 39: 386-391.
29. MIDDEL B, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatr 1997; 63: 204-209.
30. O'DWYER NJ, ADA L, NEILSON PD. Spasticity and muscle contracture following stroke. Brain 1996; 119: 1737-1749.
31. O'DWYER NJ, ADA L. Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia. Curr Opin Neurol 1996; 9: 451-455.
32. ORSNES, et al. Effect of baclofen on gait in spastric MS patients. Acta Neurol Scand 2000; 101: 244-248.
33. PENN R, et al. Continuous intrathecal Baclofen for severe spasticity. Lancet 1985; 2: 125-127.
34. PIERROT-DESEILLIGNY E, PRADAT-DIEHL P, ROBAIN G. Physiopathologie de la spasticité. Ann Readapt Med Phys 1993; 36: 309-320.
35. SINKJAER T, MAGNUSSEN I. Passive, intinsic and reflexmediated stiffness in the ankle extensors of hemiparetic patients. Brain 1994; 117: 355-363.
36. SINKJAER T, TOFT E, LARSEN K, ANDREASSEN S, HANSEN HJ. Non-reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity. Muscle Nerve 1993; 16: 69-76.
37. STUART GJ, REDMAN SJ. The role of GABAa and GABAb receptors in presynaptic inhibition of Ia EPSPs in cat spinal motoneurones. J Physiol (Lond) 1992; 447: 675-692.
38. TARDIEU C, HUET DE LA TOUR E, BRET MD, TARDIEU G. Muscle hypoextensibility in children with cerebral palsy. I.- Clinical and experimental observations. Arch Phys Med Rehabil 1982; 63: 97-102.
39. TARDIEU C, TABARY JC, TABARY C, TARDIEU G. Adaptation of connective tissue length to immobilization in the the lengthened and the shortened positions in cat soleus muscle. J Physiol (Paris) 1982; 78: 214-220.
40. WARE JE. SF-36 Health Survey. Manual and interpretation guide. Boston, Massachussets: The Health Institute, New England Medical Center, 1993.
41. WILES CM, KARNI Y, NICKLIN J. Laboratory testing of muscle function in the management of neuromuscular disease. J Neurol Neurosurg Psychiatr 1990; 53: 384-387.